Fred Hutch selected Dr. Paul Nghiem’s article published in JCO “Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.” to be covered in the March 2019 issue of Science Spotlight, a monthly online publication highlighting scientific work performed by Fred Hutch investigators.
The authoritative source on Merkel cell carcinoma.
September 13, 2023
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
- Surgical excision
- Mohs micrographic surgery
- Radiation therapy
- Complementary & alternative therapies
- Clinical trials
- Adjuvant Avelumab in Merkel Cell Carcinoma Trial
- Surgically Treated Adjuvant Merkel Cell Carcinoma with Pembrolizumab (STAMP) Trial